Addition of Biologic KRYSTEXXA® (pegloticase) Expands and Diversifies Horizon’s Orphan Business; Leverages Rheumatology Expertise and Infrastructure; Transaction Is Expected to Be Immediately Accretive to Adjusted EBITDA in 2016; Conference Call Today at 8 a.m. ET to Discuss Transaction DUBLIN, IRELAND–(Marketwired – Dec 11, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on […]

For the eighth year, Med Ad News has chosen three Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.

Getting face time with physicians might be getting easier – or it might not, according to two recent research reports on the state of play for pharma sales reps.

PDI to Focus on Growing Molecular Diagnostics Business; Plans to Change Name to Interpace Diagnostics Group PDI to receive $25.5 to $32.5 million up front cash payment and a contingent earnout payment Combination Would Create A Global Leader in Healthcare Commercial Services   PARSIPPANY, N.J. & YARDLEY, Pa., Nov. 2, 2015 /PRNewswire/ — PDI, Inc. (Nasdaq: […]

Axtria, a big data analytics firm, is conducting five back-to-back knowledge sharing sessions on Pharma commercial operations from Sept 16-Nov 11, 2015, to share key insights on topics related to promotion response modeling, sales planning, deployment, targeting and compensation.

Mobile technology can give Pharmaceutical companies the boost it needs to improve marketing effective­ness and sales performance.